Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
1.940
-0.030 (-1.52%)
At close: Oct 17, 2025, 4:00 PM EDT
1.950
+0.010 (0.52%)
After-hours: Oct 17, 2025, 7:59 PM EDT
Milestone Pharmaceuticals Market Cap
Milestone Pharmaceuticals has a market cap or net worth of $189.94 million as of October 17, 2025. Its market cap has increased by 91.33% in one year.
Market Cap
189.94M
Enterprise Value
202.91M
1-Year Change
91.33%
Ranking
Category
Stock Price
$1.94
Market Cap Chart
Since May 9, 2019, Milestone Pharmaceuticals's market cap has decreased from $363.46M to $189.94M, a decrease of -47.74%. That is a compound annual growth rate of -9.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2025 | 192.87M | 23.38% |
| Dec 31, 2024 | 156.32M | 117.39% |
| Dec 29, 2023 | 71.91M | -57.49% |
| Dec 30, 2022 | 169.15M | -38.80% |
| Dec 31, 2021 | 276.39M | 38.33% |
| Dec 31, 2020 | 199.81M | -49.04% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 742.04B |
| Johnson & Johnson | 460.40B |
| AbbVie | 399.63B |
| UnitedHealth Group | 327.08B |
| AstraZeneca | 262.65B |
| Novartis AG | 252.43B |
| Novo Nordisk | 251.88B |
| Abbott Laboratories | 225.30B |